Skip to main content

What are you looking for?

Write the name, title or any keyword related to what you are looking for and select which content category it belongs to.

News

Vall d'Hebron participates in a study that shows that the prone position in non-intubated patients with severe COVID-19 improves their prognosis

This major research opens the door to a change in current clinical practice to incorporate this treatment as part of the medical routine for non-intubated COVID-19 patients.

News

Vall d'Hebron, designat pel CatSalut com a Unitat d'Expertesa Clínica (UEC) en els àmbits de les malalties minoritàries immunitàries de l'àrea d’autoimmunes sistèmiques

Vall d'Hebron ha obtingut la designació com a Unitat d'Expertesa Clínica per part de CatSalut pels àmbits de les malalties minoritàries immunitàries de l'àrea d'autoimmunes sistèmiques.

News

Vall d'Hebron participates in an international study that associates new genetic and immunological defects with severe COVID-19

While genetic errors are more common in younger patients, autoantibodies against type I interferons appear mainly in older patients.

News

Vall d'Hebron publishes the first results of a study to implement a rapid stroke treatment pathway

The method proposes to transfer patients with stroke symptoms directly to the angiography room in order to reduce the time of action.

News

Dr. Antoni Soriano, interviewed on MedPage Today for his study that demonstrated low transmissivity of COVID-19 in children

"Child-centered measures will have little impact on reducing COVID-19, and if they are too harsh they can affect the well-being of this population", says Dr. Soriano in the prestigious publication.

News

Vall d'Hebron tests robotic thrombectomy for stroke with a pioneering study in Europe

The procedure, led by Dr. Alejandro Tomasello, aims to reduce intervention time to a minimum by working over long distances.

News

A study on the behaviour of Covid-19 in nursing homes shows that some comorbidities and symptoms have a strong predictive value for mortality

The research conducted by the Vall d'Hebron University Hospital in cooperation with the Catalan Association of Care Resources (ACRA) analyses the effects of Covid-19 in Catalan residential centres.

News

“Som de ciències”, el casal d’estiu per a fills i filles de professionals de Vall d’Hebron, apropa la ciència als infants en una edició centrada en els virus

“Som de ciències”, el casal d’estiu per a fills i filles de professionals de Vall d’Hebron, apropa la ciència als infants en una edició centrada en els virus

News

New strategies to fight aggressive breast cancer

CIBER-BBN and VHIR researchers design a new system to transport a drug effective against tumour stem cells, the most resistant ones, through nanoparticles.

News

IMIDomics, a Vall d'Hebron spin-off, raises $16.5 million to develop new drugs against immunomediated inflammatory diseases

This investment will allow IMIDomics to accelerate the identification of new therapeutic targets and the development of new drugs for immune-mediated inflammatory diseases (IMID).

News

Six Vall d'Hebron research groups receive grants from the Strategic Plan for Research and Innovation in Health (PERIS)

The projects will investigate issues such as stroke and endometrial cancer prevention.

News

A new model for studying metastasis enables faster and more affordable preliminary analysis

A new strategy has been developed to identify genes, drugs, and cellular pathways that regulate the metastasis process using laboratory models.

News

The solidarity challenge to find a cure for GNB1 encephalopathy achieves its first goal raising more than €50,000

The micro-donation initiative is being carried out by Marc León, together with the relatives of the patients, for a research project in gene therapy headed by Dr. Miguel Chillón.

News

Dr. María José Soler, elected editor-in-chief of the Clinical Kidney Journal

Dr. María José Soler, nephrologist at Vall d'Hebron and the VHIR, will become, in June 2022, the first editor-in-chief of the specialized journal Clinical Kidney Journal.

News

Vall d'Hebron participates in the largest study on non-rhabdomyosarcoma type paediatric soft tissue sarcomas

The pediatric surgeon Gabriela Guillén is a co-author in this study of the European Paediatric Soft Tissue Sarcoma Study Group (EpSSG) that lays the foundations for the treatment of this type of tumors.

News

Vall d'Hebron publishes four innovative works on different systemic diseases

Articles from the Systemic Diseases research group at the VHIR focus on scleroderma, antiphospholipid syndrome, Sjögren's syndrome, and the relationship between cancer and inflammatory myopathy.

News

Ona Futura Foundation donates €40,000 for research on immune disorders related to pregnancy in Vall d’Hebron

Ona Futura Foundation has signed a donation agreement with the Vall d'Hebron Research Institute (VHIR) to contribute to research on various immune disorders related to the pregnancy process.

News

Dr. Antoni Soriano, awarded by the European Society of Paediatric Infectious Diseases (ESPID)

The VHIR researcher has been recognized for his research on the low transmissibility of COVID-19 from pediatric patients.

News

Vall d'Hebron leads a multicenter study that will assess a faster workflow for the management of patients with stroke

The international multi-centric study WE-TRUST will assess the impact of the "Direct to Angiography" approach thanks to a computed tomography technology developed and improved by Philips.

News

Una nova calculadora per predir la mortalitat en pacients amb endocarditis infecciosa podria salvar vides

L'eina està disponible online i permet ajudar a la presa de decisions mèdiques en pacients amb endocarditis infecciosa sotmesos a cirurgia cardíaca, una operació d'alt risc.